D16H (p.Asp16His) variant of DYSF (Dysferlin)

D16H (p.Asp16His) in DYSF (Dysferlin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.78 / 1. The record also includes population frequency data, published literature, and structural context.

D16H (p.Asp16His) variant details